1- (1-Benzothiophen-4-yl) piperazine Hydrochloride CAS 913614-18-3 Ịdị ọcha> 98.0% (HPLC) Brexpiprazole Intermediate Factory

Nkọwa dị mkpirikpi:

1- (1-Benzothiophen-4-yl) Piperazine Hydrochloride

Nọmba: 913614-18-3

Dị ọcha:> 99.0% (HPLC)

Ọdịdị: White ka Gbanyụọ-Ọcha ntụ ntụ

Ọkara nke Brexpiprazole (CAS: 913611-97-9)

E-Mail: alvin@ruifuchem.com

Zitere anyị email

Nkọwa ngwaahịa

Ngwaahịa ndị emetụtara

Mkpado ngwaahịa

Nkọwa:

Ruifu Chemical Supply Brexpiprazole Intermediates
Brexpiprazole CAS 913611-97-9
7-Hydroxyquinolinone CAS 70500-72-0
4-Bromobenzo [b] thiophene CAS 5118-13-8
1- (1-Benzothiophen-4-yl) piperazine Hydrochloride CAS 913614-18-3
7- (4-Chlorobutoxy) quinolin-2(1H) -otu CAS 913613-82-8
4-Chlorobenzo[b]thiophene CAS 66490-33-3

Njirimara kemịkalụ:

Aha Chemical	1- (1-Benzothiophen-4-yl) Piperazine Hydrochloride
Ụdị okwu	Brexpiprazole Intermediate 2;1-Benzo [b] thien-4-yl-Piperazine Hydrochloride;1-Benzo [b] thien-4-ylpiperazine Monohydrochloride
Nọmba CAS	913614-18-3
Nọmba CAT	RF-PI1034
Ọnọdụ Ahịa	N'ahịa, Ikike Mmepụta 100MT/Afọ
Usoro ihe omimi	C12H15ClN2S
Ibu molekụla	254.7789
Ụdị	Ruifu Chemical

Nkọwapụta:

Ihe	Nkọwapụta
Ọdịdị	Ọcha ka Gbanyụọ-Ọcha ntụ ntụ
njirimara	Oge njide nke nlele ahụ kwekọrọ na ọkọlọtọ ntụaka
Ụzọ ịdị ọcha / nyocha	> 99.0% (HPLC)
Ọnwụ na ihicha	<0.50%
Mmiri (KF)	<0.50%
Ihe fọdụrụ na mgbanye	<0.20%
Ihe ndị emetụtara	(HPLC)
Ọdịghị ọcha nke Onye ọ bụla	<0.50%
Mgbakọta adịghị ọcha	<1.00%
Spectrum infrared	Dabara na Ọdịdị
Ọnụ ego nke Proton NMR Spectrum	Dabara na Ọdịdị
Nlele ọkọlọtọ	Standardkpụrụ ụlọ ọrụ
Ojiji	Ọkara nke Brexpiprazole (CAS: 913611-97-9)

Ngwungwu & Nchekwa:

ngwugwu: Kalama, Aluminom foil bag, 25kg / Cardboard Drum, ma ọ bụ dị ka ndị ahịa chọrọ

Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ìhè na mmiri mmiri

Uru:

Ajụjụ:

Ngwa:

1- (1-Benzothiophen-4-yl) piperazine Hydrochloride (CAS: 913614-18-3) bụ etiti nke Brexpiprazole (CAS: 913611-97-9).Brexpiprazole bụ ụdị antipsychotic na-adịghị ahụkebe.Ọ bụ onye na-anabata dopamine D2 akụkụ agonist.Dị ka ihe ọhụrụ serotonin-dopamine modulator, enwere ike iji ya mee ihe maka ọgwụgwọ schizophrenia, yana maka ọgwụgwọ mgbakwunye maka ịda mbà n'obi.Ọ nwekwara ike inye nrụpụta ọrụ yana nnabata maka ọgwụgwọ mgbakwunye akwadoro ụdị nsogbu ịda mbà n'obi (MDD).Ọgwụ ahụ na-egosipụta profaịlụ ọgwụ pụrụ iche, na-eme dị ka agonist akụkụ nke serotonin 5-HT1A na dopamine D2 ndị na-anabata ya na dị ka onye na-emegide 5-HT2A na noradrenaline α1B / 2C, yana njikọ njikọ subnanomolar yiri ya.Ọgwụ, nke Otsuka na Lundbeck mepụtara, kwadoro na 2015 site na FDA maka ọgwụgwọ schizophrenia na dịka ọgwụgwọ mgbakwunye maka ịda mbà n'obi.